四价人乳头瘤病毒疫苗与自主神经功能障碍综合征的关联:丹麦女性自对照病例系列分析
该研究基于丹麦全国登记数据,采用自对照病例系列设计,纳入869例10至44岁丹麦出生女性自主神经功能障碍综合征患者。结果显示,接种四价HPV疫苗后365天内,复合结局及个别综合征的发生率均无统计学显著增加,不支持因果关联,但不能排除最高32%的风险增加。
要点
- 四价HPV疫苗接种后365天内,自主神经功能障碍综合征复合结局发生率无显著增加(RR 0.99,95%CI 0.74-1.32)。
- 慢性疲劳综合征、复杂性区域疼痛综合征、体位性心动过速综合征单独分析亦无显著关联。
- 结果不支持四价HPV疫苗与上述综合征存在因果关联,但不能排除最高32%的风险增加。
核心结论
- 四价HPV疫苗接种与慢性疲劳综合征、复杂性区域疼痛综合征或体位性心动过速综合征,无论单独或复合结局,均无因果关联证据。
- 不能正式排除最高32%的风险增加,但研究统计效能提示任何综合征发生率的大幅增加不太可能。
研究设计与样本
- 基于人群的自对照病例系列研究,使用丹麦全国登记数据。
- 主要分析为调整年龄和季节后,比较接种与未接种四价HPV疫苗女性的复合结局发生率比(95%CI)。
主要发现
- 随访10 581 902人年,识别869例自主神经功能障碍综合征患者:慢性疲劳综合征136例,复杂性区域疼痛综合征535例,体位性心动过速综合征198例。
- 接种后365天风险期内,复合结局发生率比为0.99(95%CI 0.74-1.32)。
- 慢性疲劳综合征发生率比为0.38(95%CI 0.13-1.09),复杂性区域疼痛综合征为1.31(95%CI 0.91-1.90),体位性心动过速综合征为0.86(95%CI 0.48-1.54)。
临床怎么用
- 在全科咨询中,可告知女性患者四价HPV疫苗接种与上述自主神经功能障碍综合征无因果关联证据。
- 对于接种后出现相关症状者,应基于临床评估排除其他病因,无需预先归因于疫苗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association between quadrivalent human papillomavirus vaccination and syndromes with autonomic dysfunction, such as chronic fatigue syndrome, complex regional pain syndrome, and postural orthostatic tachycardia syndrome. DESIGN: Population-based self-controlled case series. SETTING: Information on human papillomavirus vaccinations and selected syndromes with autonomic dysfunction (chronic fatigue syndrome, complex regional pain syndrome, and postural orthostatic tachycardia syndrome) identified using ICD-10 (international classification of diseases, revision 10) diagnostic codes from Danish nationwide registers. PARTICIPANTS: 869 patients with autonomic dysfunction syndromes from a cohort of 1 375 737 Danish born female participants aged 10 to 44 years during 2007-16. MAIN OUTCOME MEASURES: Self-controlled case series rate ratios (95% confidence intervals) of the composite outcome of chronic fatigue syndrome, complex regional pain syndrome, and postural orthostatic tachycardia syndrome, adjusted for age and season, comparing female participants vaccinated and unvaccinated with the quadrivalent human papillomavirus vaccine. Chronic fatigue syndrome, complex regional pain syndrome, and postural orthostatic tachycardia syndrome were also considered separately in secondary analyses. RESULTS: During 10 581 902 person years of follow-up, 869 female participants with syndromes of autonomic dysfunction (136 with chronic fatigue syndrome, 535 with complex regional pain syndrome, and 198 with postural orthostatic tachycardia syndrome) were identified. Quadrivalent human papillomavirus vaccination did not statistically significantly increase the rate of a composite outcome of all syndromes with autonomic dysfunction in a 365 day risk period following vaccination (rate ratio 0.99, 95% confidence interval 0.74 to 1.32) or the rate of any individual syndrome in the risk period (chronic fatigue syndrome (0.38, 0.13 to 1.09), complex regional pain syndrome (1.31, 0.91 to 1.90), or postural orthostatic tachycardia syndrome (0.86, 0.48 to 1.54)). CONCLUSIONS: When vaccination is introduced, adverse events could occur in close temporal relation to the vaccine purely by chance. These results do not support a causal association between quadrivalent human papillomavirus vaccination and chronic fatigue syndrome, complex regional pain syndrome, or postural orthostatic tachycardia syndrome, either individually or as a composite outcome. An increased risk of up to 32% cannot be formally excluded, but the statistical power of the study suggests that a larger increase in the rate of any syndrome associated with vaccination is unlikely.
引用
- Hviid A, Thorsen NM, Valentiner-Branth P, et al. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis. BMJ. 2020. PMID: 32878745. doi:10.1136/bmj.m2930
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。